Skylight Health Announces Closing of Public Offering of 275,000 Shares of Series A Cumulative Redeemable Perpetual Preferred Stock
TORONTO, Dec. 7 2021 (GLOBE NEWSWIRE) — Skylight Health Group Inc. (NASDAQ:SLHG; TSXV: SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, today announced the closing of its previously announced underwritten registered offering of 275,000 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares (the “Series A Preferred Shares”) at a price to the public of US$21 per share for gross proceeds of US$5,775,000 before deducting for underwriter’s fees and offering expenses; proceeds from the offering will be used towards working capital, corporate related activities, and capital for future mergers & acquisitions. The shares of Series A Preferred Stock trade on the Nasdaq Capital Market under the symbol “SLHGP.”
The Benchmark Company, LLC acted as Sole Book Running Manager for the Offering.
The Series A Preferred Shares were offered under the Company’s shelf registration statement on Form F-10, declared effective by the United States Securities and Exchange Commission (the “SEC”) (the “Registration Statement”), and the Company’s existing Canadian amended and restated short form base shelf prospectus (the “Base Shelf Prospectus”) dated October 4, 2021. The prospectus supplement relating to the Offering (together with the Base Shelf Prospectus and the Registration Statement) has been filed with the securities commission in British Columbia, Alberta, Manitoba and Ontario and with the SEC in the United States.
No securities regulatory authority has either approved or disapproved of the contents of this press release. This press release is for information purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. A final prospectus supplement and an accompanying prospectus relating to the offering has been filed with the SEC and is available on the SEC’s website at www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus relating to the offering may also be obtained from The Benchmark Company, LLC, Attn: Prospectus Department, 150 E. 58th Street, 17th floor, New York, NY 10155 or by calling 212-312-6700 or by emailing prospectus@benchmarkcompany.com.
